Plug and Play announces expansion into Seattle along with Partnership with SBI Holdings and SNBL and Future Participation as co-GP in SBI US Gateway Fund
The partnership comprises the establishment of Plug and Play Seattle with SBI Holdings and SNBL as the Founding Anchor partners and Plug and Play’s future participation as co-GP in the $40M SBI US Gateway Fund Plug and Play expands presence to Seattle, Washington, in strategic collaboration wi
Benzinga Announces Winners for the 2024 Global Fintech Awards
NEW YORK, Nov. 19, 2024 /PRNewswire/ — Benzinga, the leading financial media platform for next-generation investors, is thrilled to announce the winners and runners-up of its 10th annual Benzinga Global Fintech Awards. The prestigious event, held at Convene Brookfield Place in New York City, c
Greater Houston Resiliency Initiative Progress Update: CenterPoint Energy Makes Significant Advances on Critical Resiliency Actions
Company has installed or replaced nearly 4,600 stronger storm-resilient poles; cleared more than 800 miles of higher-risk vegetation; undergrounded more than 100 miles of power lines; and installed dozens of new, intelligent grid switching devices HOUSTON, Nov. 19, 2024 /PRNewswire/ — CenterPo
AdvaMed Statement on President-elect Trump’s Intent to Nominate Dr. Oz to Lead CMS
WASHINGTON, Nov. 19, 2024 /PRNewswire/ — AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on President-elect Trump’s announcement that he intends to nominate Dr. Mehmet Oz to serve as Administrator of the Centers for Medicare &
Samsung Biologics signs manufacturing deal with European pharmaceutical company
The company will provide manufacturing services through 2031 in deals worth over USD 668 million Samsung Biologics’ cumulative contract value for 2024 surpasses USD 4 billion with latest deals INCHEON, South Korea, Nov. 20, 2024 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a global
Epigenic Therapeutics to Enter Clinical Development of EPI-003: A First-in-Class Epigenetic Inactivator for the Treatment of Chronic Hepatitis B
SHANGHAI, Nov. 19, 2024 /PRNewswire/ — Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy, today announced that it has received approval of clinical trial application (CTA) from the New Zealand Medicines and Medical Devices Sa
Warringtonfire Australia Rebrands to Jensen Hughes, Strengthening Global Fire Safety Engineering, Fire Testing and Fire Assessment Services
Integration expands Jensen Hughes’ fire testing, fire assessment and fire safety engineering expertise across Australia and the Pacific region. SYDNEY, Nov. 20, 2024 /PRNewswire/ — Jensen Hughes, a global leader in safety, security and risk-based engineering and consulting, announced tod
Moatable Reports Third Quarter 2024 Financial Results
PHOENIX, Nov. 19, 2024 /PRNewswire/ — Moatable, Inc. (OTC: MTBLY) (“Moatable” or the “Company”), a leading US-based SaaS company, today reported its third quarter 2024 financial results. Third Quarter 2024 Financial Highlights Revenue increased 26% over Q3 2023 to $16.7
Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600
NEW YORK, Nov. 19, 2024 /PRNewswire/ — S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE: ENV) in the
InsurTech Market to Grow by USD 77.41 Billion (2024-2028), Driven by the Need to Improve Business Efficiency, with AI Redefining Market Landscape – Technavio
NEW YORK, Nov. 19, 2024 /PRNewswire/ — Report with market evolution powered by AI – The global insurtech market size is estimated to grow by USD 77.41 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 42.35% during the forecast period
